{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:05:49Z","timestamp":1780934749147,"version":"3.54.1"},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,9,1]]},"DOI":"10.2169\/internalmedicine.2874-23","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T22:15:52Z","timestamp":1706739352000},"page":"2445-2450","source":"Crossref","is-referenced-by-count":2,"title":["Successful Treatment of Epstein-Barr Virus Reactivation-associated Transverse Myelitis Following Herpes Zoster with Intravenous Rituximab in a Cord Blood Transplant Recipient"],"prefix":"10.2169","volume":"63","author":[{"given":"Keijiro","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-Ich","family":"Imadome","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine for Virus Infections, National Center for Child Health and Development, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Sumi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nagano Red Cross Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Beh SC, Greenberg BM, Frohman T, Frohman EM. Transverse myelitis. Neurol Clin 31: 79-138, 2013.","DOI":"10.1016\/j.ncl.2012.09.008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hierro XM del, Halalau A. Cytomegalovirus-related transverse myelitis in an immunocompetent host: a subacute onset of an immune-mediated disease? BMJ Case Rep 2017: bcr2017220563, 2017.","DOI":"10.1136\/bcr-2017-220563"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Zhang N, Zuo Y, Jiang L, Peng Y, Huang X, Zuo L. Epstein-Barr virus and neurological diseases. Front Mol Biosci 8: 816098, 2021.","DOI":"10.3389\/fmolb.2021.816098"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Soldan SS, Lieberman PM. Epstein-Barr virus and multiple sclerosis. Nat Rev Microbiol 21: 51-64, 2023.","DOI":"10.1038\/s41579-022-00770-5"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Pender MP. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis. Neuroscientist 17: 351-357, 2011.","DOI":"10.1177\/1073858410381531"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Poorthuis MHF, Battjes S, Dorigo-Zetsma JW, de Kruijk JR. Primary Epstein-Barr virus infection in immunocompetent patients with acute transverse myelitis and a combination of polyradiculitis and anterior horn syndrome as neurological manifestations. BMJ Case Rep 2018: bcr2018225333, 2018.","DOI":"10.1136\/bcr-2018-225333"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Albany C, Psevdos G, Balderacchi J, Sharp VL. Epstein-Barr virus myelitis and Castleman's disease in a patient with acquired immune deficiency syndrome: a case report. J Med Case Rep 5: 209, 2011.","DOI":"10.1186\/1752-1947-5-209"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Koizumi Y, Imadome KI, Ota Y, et al. Dual threat of Epstein-Barr virus: an autopsy case report of HIV-positive plasmablastic lymphoma complicating EBV-associated hemophagocytic lymphohistiocytosis. J Clin Immunol 38: 478-483, 2018.","DOI":"10.1007\/s10875-018-0500-4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Martelius T, Lappalainen M, Palom\u00e4ki M, Anttila VJ. Clinical characteristics of patients with Epstein Barr virus in cerebrospinal fluid. BMC Infect Dis 11: 281, 2011.","DOI":"10.1186\/1471-2334-11-281"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ohta M, Taga T, Nomura A, et al. Epstein-Barr virus-related lymphoproliferative disorder, cytomegalovirus reactivation, and varicella zoster virus encephalitis during treatment of medulloblastoma. J Med Virol 83: 1582-1584, 2011.","DOI":"10.1002\/jmv.22136"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ito N, Masuda T, Yamaguchi K, et al. Pneumonia and meningoencephalitis due to varicella-zoster virus reinfection and Epstein-Barr virus reactivation in a patient with rheumatoid arthritis. Intern Med 61: 2961-2965, 2022.","DOI":"10.2169\/internalmedicine.8413-21"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lee GH, Kim J, Kim HW, Cho JW. Clinical significance of Epstein-Barr virus in the cerebrospinal fluid of immunocompetent patients. Clini Neurol Neurosurg 202: 106507, 2021.","DOI":"10.1016\/j.clineuro.2021.106507"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kim S, Ahn SJ, Chu K. Epstein-Barr virus-associated acute disseminated encephalomyelitis successfully treated with rituximab: a case report. Encephalitis 1: 85-88, 2021.","DOI":"10.47936\/encephalitis.2021.00066"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lee J, Lee HS, Chu K. Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy. Encephalitis 2: 14-18, 2022.","DOI":"10.47936\/encephalitis.2021.00143"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Rubenstein JL, Combs D, Rosenberg J, et al. Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood 101: 466-468, 2003.","DOI":"10.1182\/blood-2002-06-1636"},{"key":"16","unstructured":"16. Kikuchi A, Kawada H, Iwaki Y, et al. Measurement of rituximab concentration in the cerebrospinal fluid in CNS lymphoma. Rinsho Ketsueki (Jpn J Clin Hematol) 45: 1255-1257, 2004 (in Japanese)."},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Pawate S, Sriram S. Isolated longitudinal myelitis: a report of six cases. Spinal Cord 47: 257-261, 2009.","DOI":"10.1038\/sc.2008.99"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/17\/63_2874-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T03:32:29Z","timestamp":1725679949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/17\/63_2874-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":17,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2874-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,1]]},"article-number":"2874-23"}}